AN IN-SILICO METHOD TO IDENTIFY AND ANALYZE PHYTOCOMPOUNDS FROM MEDICINAL PLANTS AS HIV-1 PROTEASE INHIBITORS Authors: Kotadiya M , PATEL K, BHADANIA M AND AJUDIA R
ABSTRACT
The most severe stage of Human Immunodeficiency Virus (HIV) infection is Acquired Immune
Deficiency Syndrome. There has been a push in recent research to extract phytochemicals from
plants to suppress HIV, but few studies have focused on the impact of these phytochemicals on
the activity of enzymes/transporters involved in the virus. One of the goals of this work is to
assess the antiviral efficacy of these chemicals against the HIV-1 protease enzyme using
computational techniques. The ADMET Lab 2 and pkCSM servers were used to determine the
Physicochemical properties and toxicity prediction of the chosen Phytocompounds. Using
Computational tools, potential structural inhibitory activities of these phytochemicals were
explored. Free binding energy analysis for antiviral activities identified two phytocompounds
with lower binding energy than Standard drug against HIV-1 protease enzyme. Among all
Phytocompounds Antheraxanthin has similar binding energy to Dolutegravir (Standard Drug)
Amentoflavone, Nimocinol and Nicotiflorin exhibited pronounced structural evidence as
potential HIV-1 protease enzyme inhibitors. On the Basis of ADMET analysis, Nimocinol is
highly recommended Phytocompound for further study.
Keywords: HIV-1, Protease enzyme, Protease inhibitors, ADMET, Drug likeliness, Anti-viral Activities
Publication date: 01/07/2024 https://ijbpas.com/pdf/2024/July/MS_IJBPAS_2024_8141.pdfDownload PDFhttps://doi.org/10.31032/IJBPAS/2024/13.7.8141